V503 Singapore | Shim Clinic
Help me about V503 ! |
Permalink: https://shimclinic.sg/v503/ |
V503 is a nonavalent HPV (human papillomavirus) recombinant vaccine. Covering HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58.
V503 [HPV (Human Papillomavirus) Nonavalent (Types 6, 11, 16, 18, 31, 33, 45, 52, and 58) Vaccine, Recombinant] – to be released in 2013
- 2007 October 12th – Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
- 2009 July 21st – A Study of V503 in Preadolescents and Adolescents (V503-002)
- 2010 May 11th – The Phase III trial is ongoing and Merck anticipates filing a Biologics License Application (BLA) in 2012
- 2010 July – Merck is recruiting for Phase III clinical trials of a nine-valent vaccine
References